Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Silvia C. Formenti, MD"'
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 4, Pp 486-493 (2018)
Accumulating evidence supports the role of radiation therapy in the induction of antitumor immunity. With recent advancements in stereotactic radiation therapy, there is increasing appreciation that, when combined with immune checkpoint blockade, the
Externí odkaz:
https://doaj.org/article/713fe2fb241842f5a020994976f45ea4
Autor:
Benjamin T. Cooper, MD, Xiaochun Li, PhD, Samuel M. Shin, MD, Aram S. Modrek, BS, Howard C. Hsu, MD, J.K. DeWyngaert, PhD, Gabor Jozsef, PhD, Stella C. Lymberis, MD, Judith D. Goldberg, ScD, Silvia C. Formenti, MD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 4, Pp 373-381 (2016)
Purpose: Maximum dose to the left anterior descending artery (LADmax) is an important physical constraint to reduce the risk of cardiovascular toxicity. We generated a simple algorithm to guide the positioning of the tangent fields to reliably mainta
Externí odkaz:
https://doaj.org/article/fff3eb81aa2c4cbeb3e212403a73ea80
Autor:
C Norman Coleman, MD, Silvia C Formenti, MD, Nelson Chao, MD, Surbhi Grover, MD, Danielle Rodin, MD, Daniel G Petereit, MD, Bhadrasain Vikram, MD, David A Pistenmaa, MD, Majid Mohiuddin, MD, Tim R Williams, MD, Nina Wendling, PhD, Lawrence Roth, MBA, Mary Gospodarowicz, MD, D Jaffray, PhD
Publikováno v:
The Lancet Global Health, Vol 4, Iss S1, p S14 (2016)
Externí odkaz:
https://doaj.org/article/59963d9dd39149839d541b4a8d9ab373
Autor:
Holliday EB; Emma B. Holliday, MD, assistant professor, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston; James A. Bonner, MD, chair, Department of Radiation Oncology, University of Alabama, Birmingham; Silvia C. Formenti, MD, chair, Department of Radiation Oncology, Weill Cornell Medical College, New York, New York; Stephen M. Hahn, MD, chair, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center; Shalom Kalnicki, MD, chair, Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, New York; Fei-Fei Liu, MD, chair, Radiation Medicine Program, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada; Benjamin Movsas, MD, chair, Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan; Clifton D. Fuller, MD, PhD, associate professor, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center; and Charles R. Thomas, Jr., MD, chair, Department of Radiation Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland., Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Fuller CD, Thomas CR Jr
Publikováno v:
Journal of healthcare management / American College of Healthcare Executives [J Healthc Manag] 2017 Sep/Oct; Vol. 62 (5), pp. 302-313.